AMPHASTAR PHARMACEUTICALS IN

Ticker: AMPH CUSIP: 03209R103 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 352,297 Value ($000) $9,435 Avg Close $25.76 Range $22.94 - $29.00
Q3 2025
Shares 366,322 Value ($000) $9,762 Avg Close $25.82 Range $20.39 - $31.26
Q2 2025
Shares 283,187 Value ($000) $6,502 Avg Close $24.82 Range $22.64 - $29.27
Q1 2025
Shares 247,858 Value ($000) $7,185 Avg Close $31.94 Range $25.89 - $39.01
Q4 2024
Shares 8,902 Value ($000) $331 Avg Close $45.73 Range $36.48 - $53.96
Q3 2024
Shares 9,076 Value ($000) $440 Avg Close $43.89 Range $36.56 - $50.62
Q2 2024
Shares 9,076 Value ($000) $363 Avg Close $41.44 Range $38.43 - $46.62
Q1 2023
Shares 22,315 Value ($000) $837 Avg Close $32.78 Range $27.58 - $38.22
Q2 2022
Shares 13,546 Value ($000) $471 Avg Close $35.69 Range $28.64 - $44.46
Q1 2022
Shares 20,900 Value ($000) $750 Avg Close $28.36 Range $22.07 - $37.16
Q4 2021
Shares 20,006 Value ($000) $466 Avg Close $20.45 Range $18.12 - $23.85